VThunter
a database for single-cell screening of virus target cells in animal kingdom
Rabbit

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus,

Latin Name: Oryctolagus cuniculus

Tested tissues: Lung, PBMC,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_0045 2021.04 10X Genomics Lung Normal 665 Link
Vthunter_100001 2021.05 10X Genomics PBMC Normal 11533 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Influenza A virus
PBMC-Endothelial cells : 98.86% ;
PBMC-DCs : 97.14% ;
PBMC-B cells : 82.96% ;
PBMC-Monocytes : 76.16% ;
Lung-Macrophages : 66.67% ;
PBMC-Monocytes : 62.36% ;
Lung-ATII : 29.79% ;
PBMC-Endothelial cells : 29.55% ;
PBMC-DCs : 27.35% ;
Lung-ATI : 21.84% ;
Lung-Fibroblasts : 55.77% ;
Lung-Secretory cells : 13.43% ;
Lung-Endothelial cells : 11.69% ;
Lung-Ciliated cells : 8.33% ;
Lung-ATII : 34.04% ;
Lung-Secretory cells : 29.85% ;
Lung-Fibroblasts : 23.08% ;
Lung-ATI : 22.53% ;
Lung-Ciliated cells : 17.86% ;
Vesicular stomatitis virus
PBMC-Endothelial cells : 98.86% ;
PBMC-DCs : 97.14% ;
PBMC-B cells : 82.96% ;
PBMC-Monocytes : 76.16% ;
Lung-Macrophages : 66.67% ;
PBMC-Monocytes : 21.20% ;
Lung-ATII : 17.02% ;
Lung-Secretory cells : 10.45% ;
Lung-Ciliated cells : 7.14% ;
Enterovirus B
PBMC-Endothelial cells : 97.73% ;
PBMC-Monocytes : 96.88% ;
PBMC-DCs : 95.92% ;
PBMC-Unknown : 43.07% ;
PBMC-B cells : 40.25% ;
Equid alphaherpesvirus 1
PBMC-Endothelial cells : 94.32% ;
PBMC-B cells : 89.04% ;
PBMC-T cells : 74.86% ;
PBMC-Monocytes : 66.65% ;
PBMC-DCs : 66.53% ;
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
Severe acute respiratory syndrome coronavirus 2
PBMC-Monocytes : 90.99% ;
PBMC-DCs : 81.63% ;
Lung-Fibroblasts : 21.15% ;
Lung-Endothelial cells : 19.48% ;
PBMC-Unknown : 15.35% ;
PBMC-DCs : 51.02% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Monocytes : 20.79% ;
Lung-Macrophages : 16.67% ;
PBMC-Unknown : 7.92% ;
PBMC-Endothelial cells : 14.77% ;
PBMC-DCs : 12.65% ;
Human mastadenovirus B
PBMC-Endothelial cells : 84.09% ;
PBMC-DCs : 24.90% ;
PBMC-B cells : 12.82% ;
PBMC-Monocytes : 12.25% ;
PBMC-Monocytes : 72.85% ;
PBMC-DCs : 57.96% ;
PBMC-Endothelial cells : 47.73% ;
Lung-T cells : 13.64% ;
PBMC-T cells : 12.04% ;
Lassa mammarenavirus
PBMC-Monocytes : 76.76% ;
PBMC-DCs : 37.96% ;
PBMC-T cells : 34.81% ;
PBMC-B cells : 27.94% ;
PBMC-Unknown : 23.76% ;
PBMC-DCs : 51.02% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Monocytes : 20.79% ;
Lung-Macrophages : 16.67% ;
PBMC-Unknown : 7.92% ;
Lung-Ciliated cells : 27.38% ;
Lung-Secretory cells : 26.87% ;
PBMC-Platelets : 25.73% ;
PBMC-Endothelial cells : 23.86% ;
PBMC-T cells : 22.81% ;
Human immunodeficiency virus 1
PBMC-B cells : 71.48% ;
PBMC-T cells : 33.42% ;
PBMC-Endothelial cells : 29.55% ;
PBMC-DCs : 27.35% ;
PBMC-Platelets : 27.18% ;
Feline immunodeficiency virus
PBMC-B cells : 71.48% ;
PBMC-T cells : 33.42% ;
PBMC-Endothelial cells : 29.55% ;
PBMC-DCs : 27.35% ;
PBMC-Platelets : 27.18% ;
Human immunodeficiency virus 2
PBMC-B cells : 71.48% ;
PBMC-T cells : 33.42% ;
PBMC-Endothelial cells : 29.55% ;
PBMC-DCs : 27.35% ;
PBMC-Platelets : 27.18% ;
Mammalian orthoreovirus
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
PBMC-Endothelial cells : 29.55% ;
Lung-ATII : 19.15% ;
PBMC-DCs : 14.29% ;
Lung-Ciliated cells : 14.29% ;
Lung-Secretory cells : 13.43% ;
Simian rotavirus A strain RRV
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
PBMC-Endothelial cells : 47.73% ;
PBMC-Platelets : 31.74% ;
PBMC-T cells : 12.08% ;
Lung-Secretory cells : 7.46% ;
PBMC-Platelets : 42.12% ;
PBMC-DCs : 37.14% ;
PBMC-Monocytes : 34.87% ;
Lung-ATII : 29.79% ;
Lung-ATI : 22.53% ;
PBMC-Endothelial cells : 29.55% ;
Lung-ATII : 19.15% ;
Lung-Ciliated cells : 14.29% ;
PBMC-DCs : 14.29% ;
Lung-Secretory cells : 13.43% ;
Human parvovirus B19
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
Lung-Macrophages : 16.67% ;
PBMC-Monocytes : 12.22% ;
PBMC-Endothelial cells : 10.23% ;
PBMC-DCs : 7.76% ;
Adeno-associated virus - 2
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
Lung-Macrophages : 16.67% ;
PBMC-Monocytes : 12.22% ;
PBMC-Endothelial cells : 10.23% ;
PBMC-DCs : 7.76% ;
Human rotavirus strain WA
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
PBMC-Endothelial cells : 47.73% ;
PBMC-Platelets : 31.74% ;
PBMC-T cells : 12.08% ;
Lung-Secretory cells : 7.46% ;
Lung-ATII : 6.38% ;
PBMC-Endothelial cells : 29.55% ;
Lung-ATII : 19.15% ;
PBMC-DCs : 14.29% ;
Lung-Ciliated cells : 14.29% ;
Lung-Secretory cells : 13.43% ;
Human gammaherpesvirus 4
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
Lung-B cells : 35.29% ;
PBMC-B cells : 11.37% ;
Echovirus E1
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
PBMC-Endothelial cells : 47.73% ;
PBMC-Platelets : 31.74% ;
PBMC-T cells : 12.08% ;
Lung-Secretory cells : 7.46% ;
Foot-and-mouth disease virus
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
PBMC-Platelets : 42.12% ;
PBMC-DCs : 37.14% ;
PBMC-Monocytes : 34.87% ;
Lung-ATII : 29.79% ;
Lung-ATI : 22.53% ;
Lung-Ciliated cells : 26.19% ;
Lung-ATII : 14.89% ;
Lung-Fibroblasts : 13.46% ;
Lung-Secretory cells : 8.96% ;
Lung-ATI : 23.55% ;
Lung-Ciliated cells : 17.86% ;
Lung-Macrophages : 16.67% ;
Lung-Secretory cells : 16.42% ;
Lung-ATII : 14.89% ;
Lung-Macrophages : 16.67% ;
PBMC-Monocytes : 12.22% ;
PBMC-Endothelial cells : 10.23% ;
PBMC-DCs : 7.76% ;
Echovirus E8
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
PBMC-Endothelial cells : 47.73% ;
PBMC-Platelets : 31.74% ;
PBMC-T cells : 12.08% ;
Lung-Secretory cells : 7.46% ;
Human betaherpesvirus 5
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
PBMC-Platelets : 42.12% ;
PBMC-DCs : 37.14% ;
PBMC-Monocytes : 34.87% ;
Lung-ATII : 29.79% ;
Lung-ATI : 22.53% ;
Lung-ATII : 34.04% ;
Lung-Secretory cells : 29.85% ;
Lung-Fibroblasts : 23.08% ;
Lung-ATI : 22.53% ;
Lung-Ciliated cells : 17.86% ;
Human metapneumovirus
PBMC-Endothelial cells : 68.18% ;
PBMC-T cells : 55.00% ;
PBMC-DCs : 48.98% ;
PBMC-B cells : 37.23% ;
PBMC-Monocytes : 37.20% ;
Lung-Macrophages : 16.67% ;
PBMC-Monocytes : 12.22% ;
PBMC-Endothelial cells : 10.23% ;
PBMC-DCs : 7.76% ;
Rhinovirus B14
PBMC-Endothelial cells : 67.05% ;
PBMC-Monocytes : 36.85% ;
PBMC-DCs : 36.33% ;
Lung-Macrophages : 33.33% ;
Lung-ATII : 8.51% ;
Coxsackievirus A21
PBMC-Endothelial cells : 67.05% ;
PBMC-Monocytes : 36.85% ;
PBMC-DCs : 36.33% ;
Lung-Macrophages : 33.33% ;
Lung-ATII : 8.51% ;
Ebola virus
PBMC-Monocytes : 65.29% ;
Lung-Ciliated cells : 23.81% ;
Lung-ATII : 19.15% ;
Lung-B cells : 17.65% ;
Lung-Secretory cells : 16.42% ;
PBMC-DCs : 51.02% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Monocytes : 20.79% ;
Lung-Macrophages : 16.67% ;
PBMC-Unknown : 7.92% ;
Lung-ATI : 50.51% ;
Lung-Macrophages : 33.33% ;
Lung-ATII : 31.91% ;
Lung-Fibroblasts : 21.15% ;
Lung-T cells : 13.64% ;
Marburg marburgvirus
PBMC-Monocytes : 65.29% ;
Lung-Ciliated cells : 23.81% ;
Lung-ATII : 19.15% ;
Lung-B cells : 17.65% ;
Lung-Secretory cells : 16.42% ;
PBMC-DCs : 51.02% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Monocytes : 20.79% ;
Lung-Macrophages : 16.67% ;
PBMC-Unknown : 7.92% ;
Rhinovirus C
Lung-Ciliated cells : 55.95% ;
PBMC-Endothelial cells : 34.09% ;
Lung-Secretory cells : 19.40% ;
PBMC-DCs : 12.65% ;
Lung-T cells : 9.09% ;
Lymphocytic choriomeningitis mammarenavirus
PBMC-DCs : 51.02% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Monocytes : 20.79% ;
Lung-Macrophages : 16.67% ;
PBMC-Unknown : 7.92% ;
Lung-Ciliated cells : 27.38% ;
Lung-Secretory cells : 26.87% ;
PBMC-Platelets : 25.73% ;
PBMC-Endothelial cells : 23.86% ;
PBMC-T cells : 22.81% ;
Zika virus
PBMC-DCs : 51.02% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Monocytes : 20.79% ;
Lung-Macrophages : 16.67% ;
PBMC-Unknown : 7.92% ;
Dengue virus
PBMC-DCs : 51.02% ;
PBMC-Endothelial cells : 50.00% ;
PBMC-Monocytes : 20.79% ;
Lung-Macrophages : 16.67% ;
PBMC-Unknown : 7.92% ;
Lung-Macrophages : 16.67% ;
PBMC-Monocytes : 10.08% ;
Polytropic murine leukemia virus
PBMC-Monocytes : 50.77% ;
PBMC-DCs : 48.57% ;
PBMC-Endothelial cells : 45.45% ;
PBMC-T cells : 38.08% ;
PBMC-B cells : 36.07% ;
Xenotropic murine leukemia virus
PBMC-Monocytes : 50.77% ;
PBMC-DCs : 48.57% ;
PBMC-Endothelial cells : 45.45% ;
PBMC-T cells : 38.08% ;
PBMC-B cells : 36.07% ;
Gibbon ape leukemia virus
Lung-Macrophages : 50.00% ;
Lung-Ciliated cells : 29.76% ;
PBMC-Endothelial cells : 29.55% ;
PBMC-DCs : 17.96% ;
PBMC-Monocytes : 15.87% ;
PBMC-Endothelial cells : 20.45% ;
Lung-Ciliated cells : 16.67% ;
PBMC-Monocytes : 12.06% ;
PBMC-DCs : 10.61% ;
PBMC-B cells : 7.78% ;
Feline leukemia virus strain B/lambda-B1
Lung-Macrophages : 50.00% ;
Lung-Ciliated cells : 29.76% ;
PBMC-Endothelial cells : 29.55% ;
PBMC-DCs : 17.96% ;
PBMC-Monocytes : 15.87% ;
PBMC-Endothelial cells : 20.45% ;
Lung-Ciliated cells : 16.67% ;
PBMC-Monocytes : 12.06% ;
PBMC-DCs : 10.61% ;
PBMC-B cells : 7.78% ;
Simian sarcoma-associated virus
Lung-Macrophages : 50.00% ;
Lung-Ciliated cells : 29.76% ;
PBMC-Endothelial cells : 29.55% ;
PBMC-DCs : 17.96% ;
PBMC-Monocytes : 15.87% ;
Simian type D retrovirus -Tsukuba
PBMC-DCs : 44.49% ;
PBMC-Endothelial cells : 38.64% ;
PBMC-B cells : 18.17% ;
PBMC-Monocytes : 12.98% ;
PBMC-T cells : 12.53% ;
Feline endogenous virus RD114
PBMC-DCs : 44.49% ;
PBMC-Endothelial cells : 38.64% ;
PBMC-B cells : 18.17% ;
PBMC-Monocytes : 12.98% ;
PBMC-T cells : 12.53% ;
Baboon endogenous virus strain M7
PBMC-DCs : 44.49% ;
PBMC-Endothelial cells : 38.64% ;
PBMC-B cells : 18.17% ;
PBMC-Monocytes : 12.98% ;
PBMC-T cells : 12.53% ;
Human mastadenovirus C
PBMC-Monocytes : 42.68% ;
PBMC-Endothelial cells : 39.77% ;
PBMC-DCs : 16.73% ;
Lung-Macrophages : 16.67% ;
Lung-ATI : 14.33% ;
PBMC-Platelets : 42.12% ;
PBMC-DCs : 37.14% ;
PBMC-Monocytes : 34.87% ;
Lung-ATII : 29.79% ;
Lung-ATI : 22.53% ;
Lung-Ciliated cells : 40.48% ;
Lung-ATII : 21.28% ;
Lung-ATI : 19.45% ;
Lung-Secretory cells : 17.91% ;
Lung-Macrophages : 16.67% ;
Human parechovirus 1
PBMC-Platelets : 42.12% ;
PBMC-DCs : 37.14% ;
PBMC-Monocytes : 34.87% ;
Lung-ATII : 29.79% ;
Lung-ATI : 22.53% ;
Human alphaherpesvirus 1
PBMC-Platelets : 42.12% ;
PBMC-DCs : 37.14% ;
PBMC-Monocytes : 34.87% ;
Lung-ATII : 29.79% ;
Lung-ATI : 22.53% ;
PBMC-Monocytes : 28.44% ;
Lung-Ciliated cells : 26.19% ;
Lung-ATII : 14.89% ;
Lung-Fibroblasts : 13.46% ;
Lung-Secretory cells : 8.96% ;
Lung-ATI : 23.55% ;
Lung-Ciliated cells : 17.86% ;
Lung-Macrophages : 16.67% ;
Lung-Secretory cells : 16.42% ;
Lung-ATII : 14.89% ;
Lung-Ciliated cells : 7.14% ;
Lung-ATII : 6.38% ;
Coxsackievirus B1
PBMC-Platelets : 42.12% ;
PBMC-DCs : 37.14% ;
PBMC-Monocytes : 34.87% ;
Lung-ATII : 29.79% ;
Lung-ATI : 22.53% ;
Lung-Ciliated cells : 40.48% ;
Lung-ATII : 21.28% ;
Lung-ATI : 19.45% ;
Lung-Secretory cells : 17.91% ;
Lung-Macrophages : 16.67% ;
Lung-ATI : 23.55% ;
Lung-Ciliated cells : 17.86% ;
Lung-Macrophages : 16.67% ;
Lung-Secretory cells : 16.42% ;
Lung-ATII : 14.89% ;
West Nile virus
PBMC-Platelets : 42.12% ;
PBMC-DCs : 37.14% ;
PBMC-Monocytes : 34.87% ;
Lung-ATII : 29.79% ;
Lung-ATI : 22.53% ;
Human gammaherpesvirus 8
PBMC-Platelets : 42.12% ;
PBMC-DCs : 37.14% ;
PBMC-Monocytes : 34.87% ;
Lung-ATII : 29.79% ;
Lung-ATI : 22.53% ;
Coxsackievirus A9
PBMC-Platelets : 42.12% ;
PBMC-DCs : 37.14% ;
PBMC-Monocytes : 34.87% ;
Lung-ATII : 29.79% ;
Lung-ATI : 22.53% ;
Lung-ATI : 23.55% ;
Lung-Ciliated cells : 17.86% ;
Lung-Macrophages : 16.67% ;
Lung-Secretory cells : 16.42% ;
Lung-ATII : 14.89% ;
Mouse mammary tumor virus
PBMC-DCs : 40.82% ;
Hepacivirus C
PBMC-DCs : 40.82% ;
Lung-ATII : 34.04% ;
Lung-Secretory cells : 29.85% ;
Lung-Fibroblasts : 23.08% ;
Lung-ATI : 22.53% ;
Lung-Ciliated cells : 17.86% ;
PBMC-Monocytes : 21.20% ;
Lung-ATII : 17.02% ;
Lung-Secretory cells : 10.45% ;
Lung-Ciliated cells : 7.14% ;
PBMC-Endothelial cells : 14.77% ;
PBMC-DCs : 12.65% ;
Lung-Ciliated cells : 10.71% ;
Lung-ATI : 7.51% ;
Canine parvovirus
PBMC-DCs : 40.82% ;
Machupo mammarenavirus
PBMC-DCs : 40.82% ;
Guanarito mammarenavirus
PBMC-DCs : 40.82% ;
Argentinian mammarenavirus
PBMC-DCs : 40.82% ;
Feline panleukopenia virus
PBMC-DCs : 40.82% ;
Human mastadenovirus D
Lung-Ciliated cells : 40.48% ;
Lung-ATII : 21.28% ;
Lung-ATI : 19.45% ;
Lung-Secretory cells : 17.91% ;
Lung-Macrophages : 16.67% ;
Coxsackievirus B6
Lung-Ciliated cells : 40.48% ;
Lung-ATII : 21.28% ;
Lung-ATI : 19.45% ;
Lung-Secretory cells : 17.91% ;
Lung-Macrophages : 16.67% ;
Coxsackievirus B3
Lung-Ciliated cells : 40.48% ;
Lung-ATII : 21.28% ;
Lung-ATI : 19.45% ;
Lung-Secretory cells : 17.91% ;
Lung-Macrophages : 16.67% ;
Coxsackievirus B5
Lung-Ciliated cells : 40.48% ;
Lung-ATII : 21.28% ;
Lung-ATI : 19.45% ;
Lung-Secretory cells : 17.91% ;
Lung-Macrophages : 16.67% ;
Human mastadenovirus F
Lung-Ciliated cells : 40.48% ;
Lung-ATII : 21.28% ;
Lung-ATI : 19.45% ;
Lung-Secretory cells : 17.91% ;
Lung-Macrophages : 16.67% ;
Coxsackievirus B2
Lung-Ciliated cells : 40.48% ;
Lung-ATII : 21.28% ;
Lung-ATI : 19.45% ;
Lung-Secretory cells : 17.91% ;
Lung-Macrophages : 16.67% ;
Human mastadenovirus A
Lung-Ciliated cells : 40.48% ;
Lung-ATII : 21.28% ;
Lung-ATI : 19.45% ;
Lung-Secretory cells : 17.91% ;
Lung-Macrophages : 16.67% ;
Coxsackievirus B4
Lung-Ciliated cells : 40.48% ;
Lung-ATII : 21.28% ;
Lung-ATI : 19.45% ;
Lung-Secretory cells : 17.91% ;
Lung-Macrophages : 16.67% ;
Human mastadenovirus E
Lung-Ciliated cells : 40.48% ;
Lung-ATII : 21.28% ;
Lung-ATI : 19.45% ;
Lung-Secretory cells : 17.91% ;
Lung-Macrophages : 16.67% ;
Nipah henipavirus
PBMC-DCs : 33.47% ;
Lung-Endothelial cells : 15.58% ;
PBMC-Endothelial cells : 9.09% ;
Lung-ATII : 8.51% ;
Lung-Fibroblasts : 7.69% ;
Hendra henipavirus
PBMC-DCs : 33.47% ;
Lung-Endothelial cells : 15.58% ;
PBMC-Endothelial cells : 9.09% ;
Lung-ATII : 8.51% ;
Lung-Fibroblasts : 7.69% ;
JC polyomavirus
PBMC-DCs : 32.65% ;
PBMC-Platelets : 21.58% ;
Feline calicivirus
PBMC-Endothelial cells : 29.55% ;
Lung-ATII : 19.15% ;
PBMC-DCs : 14.29% ;
Lung-Ciliated cells : 14.29% ;
Lung-Secretory cells : 13.43% ;
Human alphaherpesvirus 2
PBMC-Monocytes : 28.44% ;
Lung-Ciliated cells : 7.14% ;
Suid alphaherpesvirus 1
PBMC-Monocytes : 28.44% ;
Lung-Ciliated cells : 7.14% ;
Bovine alphaherpesvirus 1
PBMC-Monocytes : 28.44% ;
Oliveros mammarenavirus
Lung-Ciliated cells : 27.38% ;
Lung-Secretory cells : 26.87% ;
PBMC-Platelets : 25.73% ;
PBMC-Endothelial cells : 23.86% ;
PBMC-T cells : 22.81% ;
Feline leukemia virus strain C/FA27
Lung-Ciliated cells : 27.38% ;
Lung-ATII : 19.15% ;
PBMC-Endothelial cells : 18.18% ;
PBMC-DCs : 17.55% ;
Lung-Secretory cells : 16.42% ;
Latino mammarenavirus
Lung-Ciliated cells : 27.38% ;
Lung-Secretory cells : 26.87% ;
PBMC-Platelets : 25.73% ;
PBMC-Endothelial cells : 23.86% ;
PBMC-T cells : 22.81% ;
Canine morbillivirus
PBMC-T cells : 27.31% ;
PBMC-B cells : 22.94% ;
PBMC-Platelets : 13.90% ;
Lung-Ciliated cells : 9.52% ;
Phocine morbillivirus
PBMC-T cells : 27.31% ;
PBMC-B cells : 22.94% ;
PBMC-Platelets : 13.90% ;
Measles morbillivirus
PBMC-T cells : 27.31% ;
PBMC-B cells : 22.94% ;
PBMC-Platelets : 13.90% ;
Lung-Ciliated cells : 9.52% ;
Rinderpest morbillivirus
PBMC-T cells : 27.31% ;
PBMC-B cells : 22.94% ;
PBMC-Platelets : 13.90% ;
Human alphaherpesvirus 3
PBMC-B cells : 27.27% ;
PBMC-Endothelial cells : 22.73% ;
Lung-Secretory cells : 19.40% ;
PBMC-Monocytes : 19.31% ;
PBMC-T cells : 18.39% ;
Varicella Zoster Virus
PBMC-B cells : 27.27% ;
PBMC-Endothelial cells : 22.73% ;
Lung-Secretory cells : 19.40% ;
PBMC-Monocytes : 19.31% ;
PBMC-T cells : 18.39% ;
Coxsackievirus A16
PBMC-Monocytes : 25.70% ;
PBMC-Endothelial cells : 20.45% ;
Lung-Macrophages : 16.67% ;
PBMC-DCs : 14.69% ;
PBMC-T cells : 14.37% ;
Enterovirus A71
PBMC-Monocytes : 25.70% ;
PBMC-Endothelial cells : 20.45% ;
Lung-Macrophages : 16.67% ;
PBMC-DCs : 14.69% ;
PBMC-T cells : 14.37% ;
Porcine reproductive and respiratory syndrome virus
PBMC-DCs : 23.67% ;
PBMC-Endothelial cells : 12.50% ;
Encephalomyocarditis virus
Lung-ATII : 21.28% ;
Lung-Fibroblasts : 19.23% ;
Lung-Macrophages : 16.67% ;
Human rhinovirus A2
PBMC-Monocytes : 21.20% ;
Lung-ATII : 17.02% ;
Lung-Secretory cells : 10.45% ;
Lung-Ciliated cells : 7.14% ;
Amphotropic murine leukemia virus
PBMC-Endothelial cells : 20.45% ;
Lung-Ciliated cells : 16.67% ;
PBMC-Monocytes : 12.06% ;
PBMC-DCs : 10.61% ;
PBMC-B cells : 7.78% ;
Hepatitis E virus
Lung-ATI : 15.36% ;
Lung-Endothelial cells : 9.09% ;
Human papillomavirus type 16
PBMC-T cells : 15.32% ;
Lung-ATII : 14.89% ;
Lung-Ciliated cells : 11.90% ;
Lung-B cells : 11.76% ;
Lung-Secretory cells : 7.46% ;
Ecotropic murine leukemia virus
Lung-Ciliated cells : 14.29% ;
Lung-B cells : 11.76% ;
PBMC-DCs : 7.35% ;
Coxsackievirus A10
Lung-Ciliated cells : 13.10% ;
Lung-Fibroblasts : 9.62% ;
Lung-Endothelial cells : 7.79% ;
Lung-Secretory cells : 7.46% ;
Small ruminant morbillivirus
Lung-Ciliated cells : 9.52% ;
Respiratory syncytial virus
PBMC-Monocytes : 8.82% ;
Rabies lyssavirus
PBMC-DCs : 6.53% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China